Creo Medical Group PLC (LON:CREO) Insider Acquires £19,600 in Stock

Creo Medical Group PLC (LON:CREO) insider Richard John Rees bought 98,000 shares of the stock in a transaction dated Thursday, October 24th. The shares were purchased at an average price of GBX 20 ($0.26) per share, for a total transaction of £19,600 ($25,447.94).

Creo Medical Group Price Performance

CREO opened at GBX 20 ($0.26) on Friday. Creo Medical Group PLC has a fifty-two week low of GBX 19 ($0.25) and a fifty-two week high of GBX 50 ($0.65). The company has a market capitalization of £72.36 million, a P/E ratio of -333.33 and a beta of 0.86. The stock has a fifty day moving average of GBX 25.91 and a 200-day moving average of GBX 31.02. The company has a debt-to-equity ratio of 29.96, a quick ratio of 2.19 and a current ratio of 3.24.

Creo Medical Group Company Profile

Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.